Dr. Scott Rowley

Dr. Robert Brodsky is a professor of medicine at the Johns Hopkins University School of Medicine. His area of clinical expertise is classical hematology and haploidentical bone marrow transplant for sickle cell disease and aplastic anemia. Dr. Brodsky serves as the director of the Division of Hematology and the T32 Training Program. He is the Johns Hopkins Family Professor of Medicine and Oncology. He received his M.D. from Hahnemann University. He completed his residency at the Vanderbilt University School of Medicine. He performed a fellowship in hematology at the National Institutes of Health and a fellowship in oncology at Johns Hopkins. He joined the Johns Hopkins faculty in 1997. From 2017 to 2022 he served as Associate Editor to The Journal of Clinical Investigation (JCI) and Secretary to American Society of Hematology (ASH). He serves as President of The American Society of Hematology (ASH) in 2023. Dr. Brodsky is rated as an Elite provider by MediFind in the treatment of D-Plus Hemolytic Uremic Syndrome. His top areas of expertise are Paroxysmal Nocturnal Hemoglobinuria (PNH), Paroxysmal Cold Hemoglobinuria, Anemia, Bone Marrow Transplant, and Splenectomy.

Catherine Broome is a Hematologist in Washington, Washington, D.c.. Dr. Broome is rated as a Distinguished provider by MediFind in the treatment of D-Plus Hemolytic Uremic Syndrome. Her top areas of expertise are Autoimmune Hemolytic Anemia, Chronic B-Cell Leukemia (CBCL), Thrombocytopenia, Bone Marrow Aspiration, and Splenectomy.

Dr. Michael Cole is a distinguished graduate of the US Air Force Academy (2006), and as an Alberta Bart Holaday Scholar went on to complete his Doctor of Philosophy in Biochemistry (2010) at University of Oxford under the direction of Prof Paul Wentworth Jr. and Prof Bob Sim. He focused his research on peptide chemistry and acyl group reactivity in thioester-containing proteins such as complement proteins, C3 and C4. He fulfilled his Air Force commitment as a chemist and Assistant Professor of Chemistry at the US Air Force Academy. He came to Johns Hopkins University for medical school in 2014. Since that time, he has stayed at Johns Hopkins completing his medical degree (2018), internal medicine residency training (2021), and hematology fellowship (2024). In 2024, he joined the Division of Hematology as an Instructor. Dr. Cole is rated as an Advanced provider by MediFind in the treatment of D-Plus Hemolytic Uremic Syndrome. His top areas of expertise are Hemolytic-Uremic Syndrome, D-Plus Hemolytic Uremic Syndrome, D-Minus Hemolytic Uremic Syndrome, and Atypical Hemolytic Uremic Syndrome (aHUS).